Bio-Techne debt and dilution—

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

—

Cash & equivalents

USD millions

$264.712M

Net debt

USD millions

—

Debt / equity

—

Debt / assets

—

Net debt / EBITDA

× · TTM

—

Debt / FCF

× · TTM

—

Interest coverage

× · TTM

26.16×

Current ratio

4.55×

Diluted shares

Million shares

157.21M shares

Basic shares

Million shares

156.17M shares

Share count growth

0.29%

Share repurchases

USD millions

$41.651M

Quarterly data

Bio-Techne capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q4	Jun 30, 2026	—	264.71	—	—	—	—	—	26.16×	4.55×	157.21	156.17	0.29%	41.65
FY 2026 Q3	Mar 31, 2026	—	209.82	—	—	—	—	—	15.88×	4.49×	157.4	156.33	-0.66%	0
FY 2026 Q2	Dec 31, 2025	—	172.88	—	—	—	—	—	12.59×	4.54×	157	155.84	-1.64%	0
FY 2026 Q1	Sep 30, 2025	—	144.96	—	—	—	—	—	11.86×	4.22×	156.36	155.46	-1.93%	0.02
FY 2025 Q4	Jun 30, 2025	—	162.19	—	—	—	—	—	12.02×	3.46×	156.87	155.73	-1.36%	100.06
FY 2025 Q3	Mar 31, 2025	—	140.67	—	—	—	—	—	19.45×	3.71×	158.94	157.37	0.04%	100.05
FY 2025 Q2	Dec 31, 2024	—	177.55	—	—	—	—	—	18.47×	3.94×	160.63	158.43	0.57%	—
FY 2025 Q1	Sep 30, 2024	—	187.54	—	—	—	—	—	14.66×	4.56×	161.12	158.53	0.25%	—
FY 2024 Q4	Jun 30, 2024	—	151.79	—	—	—	—	—	13.13×	3.87×	160.64	157.87	0.23%	0
FY 2024 Q3	Mar 31, 2024	—	139.92	—	—	—	—	—	15.09×	4.08×	160.5	157.31	-0%	0
FY 2024 Q2	Dec 31, 2023	—	130.13	—	—	—	—	—	18.8×	4.37×	160.06	157.53	0.33%	—
FY 2024 Q1	Sep 30, 2023	—	148.66	—	—	—	—	—	24.23×	4.63×	161.94	158.13	0.77%	—
FY 2023 Q4	Jun 30, 2023	—	180.57	—	—	—	—	—	26.66×	4.84×	162.12	157.5	0.45%	0
FY 2023 Q3	Mar 31, 2023	—	127.28	—	—	—	—	—	28.45×	4.04×	161.62	157.31	0.14%	0
FY 2023 Q2	Dec 31, 2022	—	164.68	—	—	—	—	—	26.49×	4.4×	161.75	157.01	-0.15%	0
FY 2023 Q1	Sep 30, 2022	—	165.26	—	—	—	—	—	24.78×	4.01×	162.17	156.93	0.35%	19.56
FY 2022 Q4	Jun 30, 2022	255.91	172.57	83.34	0.15×	11.15%	0.21×	0.91×	26.23×	3.44×	163.59	156.8	0.75%	58.82
FY 2022 Q3	Mar 31, 2022	259.01	160.82	98.19	0.15×	11.26%	0.26×	0.86×	23.53×	3.55×	163.88	157.09	1.07%	60.84
FY 2022 Q2	Dec 31, 2021	282.12	211.85	70.27	0.17×	12.24%	0.2×	0.92×	21.43×	3.81×	164.83	157.24	1.6%	—
FY 2022 Q1	Sep 30, 2021	300.22	196.32	103.9	0.18×	13.22%	0.3×	1.02×	19.42×	4.06×	164.63	156.38	1.45%	—
FY 2021 Q4	Jun 30, 2021	341.33	199.09	142.24	0.22×	15.08%	0.44×	1.11×	17.01×	3.35×	164.08	155.64	1.58%	0
FY 2021 Q3	Mar 31, 2021	215.43	186.14	29.3	0.14×	10.33%	0.1×	0.96×	13.62×	4.12×	162.7	155.42	1.44%	43.18
FY 2021 Q2	Dec 31, 2020	231.54	165.53	66.01	0.15×	11.2%	0.24×	1.15×	10.94×	4.61×	161.03	154.76	1.37%	—
FY 2021 Q1	Sep 30, 2020	323.64	169.4	154.24	0.22×	15.76%	0.6×	1.81×	9.42×	5.14×	160.1	154.14	1.33%	—
FY 2020 Q4	Jun 30, 2020	356.74	146.63	210.12	0.26×	17.59%	0.87×	2.32×	8.2×	4.88×	158.8	153.22	1.12%	0
FY 2020 Q3	Mar 31, 2020	419.85	156.22	263.63	0.33×	21%	1.08×	2.47×	8×	4.69×	157.74	153.21	1.41%	50.11
FY 2020 Q2	Dec 31, 2019	382.95	110.29	272.66	0.29×	19.16%	1.15×	2.32×	7.58×	4.43×	158.2	152.67	1.06%	—
FY 2020 Q1	Sep 30, 2019	486.06	99.89	386.16	0.41×	25.25%	1.65×	3.22×	7.11×	4.44×	157.01	152.13	0.89%	—
FY 2019 Q4	Jun 30, 2019	505.16	100.89	404.27	0.43×	26.81%	1.8×	3.23×	6.76×	4.05×	156.54	151.52	0.79%	0
FY 2019 Q3	Mar 31, 2019	522.27	95.56	426.7	0.46×	27.89%	1.92×	3.05×	7.64×	4.32×	155.44	151.09	0.72%	0
FY 2019 Q2	Dec 31, 2018	—	85.89	—	—	—	—	—	8.75×	4.35×	154.99	151.06	0.85%	—
FY 2019 Q1	Sep 30, 2018	561.47	94.67	466.8	0.51×	29.99%	2.29×	3.87×	10.31×	4.59×	155.25	150.79	0.86%	—
FY 2018 Q4	Jun 30, 2018	—	121.99	—	—	—	—	—	13.37×	5.01×	153.39	150.34	0.65%	—
FY 2018 Q3	Mar 31, 2018	—	86.61	—	—	—	—	—	15.06×	5.55×	152.57	150.01	0.49%	—
FY 2018 Q2	Dec 31, 2017	—	121.46	—	—	—	—	—	14.75×	3.1×	151.7	149.8	0.38%	—
FY 2018 Q1	Sep 30, 2017	—	72.46	—	—	—	—	—	14.67×	2.87×	150.82	149.5	0.25%	—
FY 2017 Q4	Jun 30, 2017	—	91.61	—	—	—	—	—	16.38×	2.57×	150.18	149.38	0.32%	—
FY 2017 Q3	Mar 31, 2017	—	59.84	—	—	—	—	—	20.22×	2.15×	149.98	149.28	0.33%	—
FY 2017 Q2	Dec 31, 2016	—	58.94	—	—	—	—	—	30.83×	2.44×	149.91	149.23	0.32%	—
FY 2017 Q1	Sep 30, 2016	—	69.59	—	—	—	—	—	55.26×	2.9×	149.89	149.12	0.3%	—
FY 2016 Q4	Jun 30, 2016	—	64.24	—	—	—	—	—	86.15×	4.69×	149.54	148.9	0.2%	—
FY 2016 Q3	Mar 31, 2016	—	65.71	—	—	—	—	—	0.89×	5.08×	149.2	148.78	0.16%	—
FY 2016 Q2	Dec 31, 2015	—	62.45	—	—	—	—	—	-1.57×	7.21×	149.2	148.76	0.28%	—
FY 2016 Q1	Sep 30, 2015	—	48.84	—	—	—	—	—	-2.39×	5.35×	149.26	148.68	0.44%	—
FY 2015 Q4	Jun 30, 2015	—	54.53	—	—	—	—	—	0.1×	6.24×	149.18	148.6	0.61%	—
FY 2015 Q3	Mar 31, 2015	—	106.45	—	—	—	—	—	—	7.65×	149.08	148.55	0.61%	—
FY 2015 Q2	Dec 31, 2014	—	92.97	—	—	—	—	—	206.43×	6.18×	148.84	148.34	0.55%	—
FY 2015 Q1	Sep 30, 2014	—	98.24	—	—	—	—	—	500.24×	6.6×	148.59	148.03	0.45%	—
FY 2014 Q4	Jun 30, 2014	—	318.57	—	—	—	—	—	—	17.79×	148.14	147.7	0.24%	—
FY 2014 Q3	Mar 31, 2014	—	123.6	—	—	—	—	—	—	13.11×	148.21	147.64	0.19%	—
FY 2014 Q2	Dec 31, 2013	—	98.4	—	—	—	—	—	—	12.63×	148.06	147.53	0.13%	—
FY 2014 Q1	Sep 30, 2013	—	83.86	—	—	—	—	—	—	13.84×	147.71	147.37	0.04%	—
FY 2013 Q4	Jun 30, 2013	—	163.79	—	—	—	—	—	—	12.76×	147.59	147.36	0.02%	1.82
FY 2013 Q3	Mar 31, 2013	—	150.71	—	—	—	—	—	—	12.01×	147.63	147.37	-0.06%	0
FY 2013 Q2	Dec 31, 2012	—	143.29	—	—	—	—	—	—	16.91×	147.6	147.34	-0.36%	0
FY 2013 Q1	Sep 30, 2012	—	130.81	—	—	—	—	—	—	15.29×	147.58	147.31	-0.72%	0
FY 2012 Q4	Jun 30, 2012	—	116.68	—	—	—	—	—	—	9.69×	147.58	147.32	-0.83%	2.32
FY 2012 Q3	Mar 31, 2012	—	95.28	—	—	—	—	—	—	9.97×	147.72	147.46	-0.69%	3.54
FY 2012 Q2	Dec 31, 2011	—	80.99	—	—	—	—	—	—	16.09×	148.11	147.86	-0.34%	7.07
FY 2012 Q1	Sep 30, 2011	—	79.24	—	—	—	—	—	—	8.35×	148.68	148.38	0.15%	10.68
FY 2011 Q4	Jun 30, 2011	—	77.61	—	—	—	—	—	—	12.67×	148.92	148.56	—	0
FY 2011 Q3	Mar 31, 2011	—	158.63	—	—	—	—	—	—	16.73×	148.78	148.48	—	0
FY 2011 Q2	Dec 31, 2010	—	135.88	—	—	—	—	—	—	18.55×	148.62	148.37	—	0
FY 2011 Q1	Sep 30, 2010	—	115.01	—	—	—	—	—	—	14.52×	148.43	148.16	—	1.94

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · TECH, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.